Ariana Abid, MD
Addiction Medicine · Sonora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sonora Community Hospital · 134 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Sonora. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abid’s office at (209) 536-5100 to ask if they take your plan before you enroll.
California Medical Board record
Licence A167020 · Current
Licensed to practise in California · since 2019 · expires 2027-12-31 · Usf Health Morsani College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Medicaid work
$85,992 in 2024
Medicaid paid $85,992 for 1,381 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 441 | $75,279 |
| Return visit (30+ min) | 416 | $6,439 |
| Long return visit (40+ min) | 110 | $3,290 |
| New patient visit (60+ min) | 22 | $662 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 118 | $323 |
| Medication list documented in medical record (COA) | 201 | $0 |
| BODY MASS INDEX DOCD | 73 | $0 |
| 2024 | 1,381 | 7 | 32 | $85,992 |
| 2023 | 552 | 6 | 30 | $38,127 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 203 | $32,687 |
| Return visit (30+ min) | 161 | $2,648 |
| New patient visit (60+ min) | 80 | $2,181 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 23 | $439 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 51 | $171 |
| Medication list documented in medical record (COA) | 34 | $0 |
Drugs they prescribed that Part D paid
$162,808
Pharmacies billed $162,808 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 18% of their Part D prescriptions (198 of 1,121) in 2024. A higher opioid share than 9 in 10 peers; the typical family medicine clinician is at 0%. Long-acting opioids: 65% of their opioid prescriptions.
984 generic and 137 brand-name prescriptions · $162,808 in drug cost · 24 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 323 | $49,387 | $153 |
| Belbuca | 69 | $43,001 | $623 |
| Buprenorphine | 53 | $12,806 | $242 |
| Linzess | 15 | $8,998 | $600 |
| Buprenorphine | 88 | $4,210 | $48 |
See all 18 drugs
| Buprenorphine-Naloxone | 323 | $49,387 | $153 |
| Belbuca | 69 | $43,001 | $623 |
| Buprenorphine | 53 | $12,806 | $242 |
| Linzess | 15 | $8,998 | $600 |
| Buprenorphine | 88 | $4,210 | $48 |
| Citalopram Hbr | 91 | $1,271 | $14 |
| Fluoxetine | 24 | $560 | $23 |
| Naltrexone | 12 | $507 | $42 |
| Gabapentin | 42 | $463 | $11 |
| Hydroxyzine | 41 | $413 | $10 |
| Duloxetine | 17 | $262 | $15 |
| Hydrocodone-Acetaminophen | 30 | $246 | $8 |
| Trazodone | 39 | $211 | $5 |
| Oxycodone | 20 | $206 | $10 |
| Quetiapine | 25 | $174 | $7 |
| Nortriptyline | 26 | $147 | $6 |
| Tramadol | 16 | $121 | $8 |
| Diazepam | 51 | $102 | $2 |
Year by year
| 2024 | 1,121 | 124 | 18% (198) | 12% | $162,808 |
| 2023 | 314 | 76 | 24% (75) | 21% | $57,135 |
| 2022 | 48 | 17 | None | 0% | $2,570 |
| 2021 | 158 | 52 | 15% (23) | 18% | $20,687 |
| 2020 | 682 | 114 | 4% (29) | None | $63,998 |
| 2019 | 545 | 104 | None | None | $49,656 |
| 2018 | 279 | 56 | None | None | $17,263 |
| 2017 | 43 | 15 | 0% (0) | None | $2,209 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Vivitrol | 13 | $22,620 | $1,740 |
| Buprenorphine-Naloxone | 113 | $10,207 | $90 |
| Belbuca | 22 | $9,885 | $449 |
| Buprenorphine | 14 | $4,175 | $298 |
| Suboxone | 12 | $2,575 | $215 |
| Gabapentin | 12 | $293 | $24 |
| Hydrocodone-Acetaminophen | 19 | $272 | $14 |
| Buprenorphine | 13 | $264 | $20 |
| Citalopram Hbr | 11 | $200 | $18 |
2022: 1 drug
| Buprenorphine-Naloxone | 22 | $2,057 | $94 |
2021: 1 drug
| Buprenorphine-Naloxone | 19 | $3,642 | $192 |
2020: 16 drugs
| Lantus Solostar | 15 | $6,416 | $428 |
| Buprenorphine-Naloxone | 11 | $1,098 | $100 |
| Duloxetine | 13 | $687 | $53 |
| Pantoprazole | 26 | $627 | $24 |
| Pregabalin | 11 | $551 | $50 |
| Atorvastatin | 41 | $528 | $13 |
| Levothyroxine | 24 | $477 | $20 |
| Lisinopril | 43 | $318 | $7 |
| Gabapentin | 13 | $285 | $22 |
| Losartan | 23 | $250 | $11 |
| Amlodipine Besylate | 23 | $186 | $8 |
| Montelukast | 12 | $176 | $15 |
| Hydrochlorothiazide | 17 | $148 | $9 |
| Carvedilol | 13 | $123 | $9 |
| Furosemide | 12 | $114 | $10 |
| Metformin | 18 | $58 | $3 |
2019: 12 drugs
| Lantus Solostar | 14 | $7,684 | $549 |
| Escitalopram | 16 | $3,466 | $217 |
| Atorvastatin | 18 | $489 | $27 |
| Levothyroxine | 17 | $418 | $25 |
| Gabapentin | 13 | $378 | $29 |
| Ranitidine | 18 | $290 | $16 |
| Amlodipine Besylate | 32 | $177 | $6 |
| Losartan | 15 | $123 | $8 |
| Simvastatin | 13 | $111 | $9 |
| Furosemide | 15 | $93 | $6 |
| Lisinopril | 22 | $86 | $4 |
| Citalopram Hbr | 13 | $34 | $3 |
2018: 4 drugs
| Atorvastatin | 14 | $468 | $33 |
| Levothyroxine | 14 | $297 | $21 |
| Ranitidine | 16 | $153 | $10 |
| Amlodipine Besylate | 18 | $61 | $3 |
Money from drug and device companies
$185 in 2025
| 2025 | 1 | 2 | None | $185 |
| 2024 | 2 | 3 | None | $49 |
| 2020 | 2 | 2 | None | $26 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Braeburn | Brixadi | $185 | 2 payments
|
See all 2 published payments
| Braeburn | Meals · 2025-08-14 | Brixadi | $119 |
| Braeburn | Meals · 2025-04-24 | Brixadi | $65 |
See earlier years (2024, 2020, 2019)
2024: $49
| Collegium Pharmaceutical | Belbuca | $34 | 2 payments
|
| Braeburn | Brixadi | $15 | 1 payment
|
2020: $26
| Pfizer | Eliquis | $13 | 1 payment
|
| Indivior | Sublocade | $13 | 1 payment
|
2019: $12
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1285154807
- Licence
- CA A167020, FL 25061California A167020: Current · expires 2027-12-31
- Trained
- University of South Florida College of Medicine, 2017
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QA0401X (207QA0401X); Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-06-24
- NPI last updated
- 2022-11-08
- NPI record certified
- 2022-11-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1920 Colorado Ave, Santa Monica, CA, 90404
This office lists an electronic records connection.